nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—Eye disorder—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Deferiprone—Convulsion—Vincristine—sarcoma	0.00217	0.00217	CcSEcCtD
Deferiprone—Cardiac disorder—Etoposide—sarcoma	0.00216	0.00216	CcSEcCtD
Deferiprone—Hypertension—Vincristine—sarcoma	0.00216	0.00216	CcSEcCtD
Deferiprone—Angiopathy—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Deferiprone—Convulsion—Mitoxantrone—sarcoma	0.00211	0.00211	CcSEcCtD
Deferiprone—Hypertension—Mitoxantrone—sarcoma	0.00211	0.00211	CcSEcCtD
Deferiprone—Immune system disorder—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Deferiprone—Mediastinal disorder—Etoposide—sarcoma	0.0021	0.0021	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.0021	0.0021	CcSEcCtD
Deferiprone—Chills—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Deferiprone—Sepsis—Doxorubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00208	0.00208	CcSEcCtD
Deferiprone—Arthralgia—Mitoxantrone—sarcoma	0.00208	0.00208	CcSEcCtD
Deferiprone—Discomfort—Mitoxantrone—sarcoma	0.00205	0.00205	CcSEcCtD
Deferiprone—Somnolence—Thiotepa—sarcoma	0.00205	0.00205	CcSEcCtD
Deferiprone—Anaphylactic shock—Vincristine—sarcoma	0.00204	0.00204	CcSEcCtD
Deferiprone—Infection—Vincristine—sarcoma	0.00203	0.00203	CcSEcCtD
Deferiprone—Dyspepsia—Thiotepa—sarcoma	0.00203	0.00203	CcSEcCtD
Deferiprone—Increased appetite—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Deferiprone—Nervous system disorder—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Deferiprone—Decreased appetite—Thiotepa—sarcoma	0.002	0.002	CcSEcCtD
Deferiprone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00199	0.00199	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Thiotepa—sarcoma	0.00199	0.00199	CcSEcCtD
Deferiprone—Decreased appetite—Dactinomycin—sarcoma	0.00199	0.00199	CcSEcCtD
Deferiprone—Fatigue—Thiotepa—sarcoma	0.00199	0.00199	CcSEcCtD
Deferiprone—Infection—Mitoxantrone—sarcoma	0.00198	0.00198	CcSEcCtD
Deferiprone—Hyperhidrosis—Vincristine—sarcoma	0.00198	0.00198	CcSEcCtD
Deferiprone—Fatigue—Dactinomycin—sarcoma	0.00197	0.00197	CcSEcCtD
Deferiprone—Pain—Thiotepa—sarcoma	0.00197	0.00197	CcSEcCtD
Deferiprone—Back pain—Etoposide—sarcoma	0.00196	0.00196	CcSEcCtD
Deferiprone—Pain—Dactinomycin—sarcoma	0.00196	0.00196	CcSEcCtD
Deferiprone—Cardiac failure—Epirubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Deferiprone—Skin disorder—Mitoxantrone—sarcoma	0.00193	0.00193	CcSEcCtD
Deferiprone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00192	0.00192	CcSEcCtD
Deferiprone—Hypotension—Vincristine—sarcoma	0.00191	0.00191	CcSEcCtD
Deferiprone—Pain in extremity—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Deferiprone—Diplopia—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Deferiprone—Osteoarthritis—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Deferiprone—Gastrointestinal pain—Thiotepa—sarcoma	0.00188	0.00188	CcSEcCtD
Deferiprone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00187	0.00187	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Vincristine—sarcoma	0.00186	0.00186	CcSEcCtD
Deferiprone—Hypotension—Mitoxantrone—sarcoma	0.00186	0.00186	CcSEcCtD
Deferiprone—Increased appetite—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Deferiprone—Urticaria—Thiotepa—sarcoma	0.00183	0.00183	CcSEcCtD
Deferiprone—Abdominal pain—Thiotepa—sarcoma	0.00182	0.00182	CcSEcCtD
Deferiprone—Body temperature increased—Thiotepa—sarcoma	0.00182	0.00182	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00181	0.00181	CcSEcCtD
Deferiprone—Abdominal pain—Dactinomycin—sarcoma	0.00181	0.00181	CcSEcCtD
Deferiprone—Body temperature increased—Dactinomycin—sarcoma	0.00181	0.00181	CcSEcCtD
Deferiprone—Cardiac failure—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Deferiprone—Decreased appetite—Vincristine—sarcoma	0.00178	0.00178	CcSEcCtD
Deferiprone—Somnolence—Mitoxantrone—sarcoma	0.00177	0.00177	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Vincristine—sarcoma	0.00176	0.00176	CcSEcCtD
Deferiprone—Fatigue—Vincristine—sarcoma	0.00176	0.00176	CcSEcCtD
Deferiprone—Convulsion—Etoposide—sarcoma	0.00176	0.00176	CcSEcCtD
Deferiprone—Dehydration—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Deferiprone—Dyspepsia—Mitoxantrone—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Hypertension—Etoposide—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Pain—Vincristine—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Osteoarthritis—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Pain in extremity—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Diplopia—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Deferiprone—Decreased appetite—Mitoxantrone—sarcoma	0.00173	0.00173	CcSEcCtD
Deferiprone—Fatigue—Mitoxantrone—sarcoma	0.00172	0.00172	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Deferiprone—Discomfort—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Deferiprone—Pain—Mitoxantrone—sarcoma	0.0017	0.0017	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Deferiprone—Hypersensitivity—Thiotepa—sarcoma	0.0017	0.0017	CcSEcCtD
Deferiprone—Hypersensitivity—Dactinomycin—sarcoma	0.00169	0.00169	CcSEcCtD
Deferiprone—Gastrointestinal pain—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Deferiprone—Anaphylactic shock—Etoposide—sarcoma	0.00166	0.00166	CcSEcCtD
Deferiprone—Asthenia—Thiotepa—sarcoma	0.00165	0.00165	CcSEcCtD
Deferiprone—Infection—Etoposide—sarcoma	0.00164	0.00164	CcSEcCtD
Deferiprone—Asthenia—Dactinomycin—sarcoma	0.00164	0.00164	CcSEcCtD
Deferiprone—Pruritus—Thiotepa—sarcoma	0.00163	0.00163	CcSEcCtD
Deferiprone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00163	0.00163	CcSEcCtD
Deferiprone—Dehydration—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Deferiprone—Abdominal pain—Vincristine—sarcoma	0.00162	0.00162	CcSEcCtD
Deferiprone—Body temperature increased—Vincristine—sarcoma	0.00162	0.00162	CcSEcCtD
Deferiprone—Skin disorder—Etoposide—sarcoma	0.00161	0.00161	CcSEcCtD
Deferiprone—Hyperhidrosis—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Deferiprone—Pancreatitis—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Deferiprone—Urticaria—Mitoxantrone—sarcoma	0.00158	0.00158	CcSEcCtD
Deferiprone—Diarrhoea—Thiotepa—sarcoma	0.00158	0.00158	CcSEcCtD
Deferiprone—Abdominal pain—Mitoxantrone—sarcoma	0.00157	0.00157	CcSEcCtD
Deferiprone—Body temperature increased—Mitoxantrone—sarcoma	0.00157	0.00157	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Deferiprone—Diarrhoea—Dactinomycin—sarcoma	0.00157	0.00157	CcSEcCtD
Deferiprone—Pancytopenia—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Deferiprone—Hypotension—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Deferiprone—Neutropenia—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Deferiprone—Hypersensitivity—Vincristine—sarcoma	0.00151	0.00151	CcSEcCtD
Deferiprone—Photosensitivity reaction—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Deferiprone—Weight increased—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Deferiprone—Pancreatitis—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Deferiprone—Somnolence—Etoposide—sarcoma	0.00147	0.00147	CcSEcCtD
Deferiprone—Hypersensitivity—Mitoxantrone—sarcoma	0.00147	0.00147	CcSEcCtD
Deferiprone—Asthenia—Vincristine—sarcoma	0.00147	0.00147	CcSEcCtD
Deferiprone—Vomiting—Thiotepa—sarcoma	0.00147	0.00147	CcSEcCtD
Deferiprone—Pneumonia—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Deferiprone—Infestation—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Deferiprone—Infestation NOS—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Deferiprone—Vomiting—Dactinomycin—sarcoma	0.00145	0.00145	CcSEcCtD
Deferiprone—Rash—Thiotepa—sarcoma	0.00145	0.00145	CcSEcCtD
Deferiprone—Dermatitis—Thiotepa—sarcoma	0.00145	0.00145	CcSEcCtD
Deferiprone—Headache—Thiotepa—sarcoma	0.00144	0.00144	CcSEcCtD
Deferiprone—Rash—Dactinomycin—sarcoma	0.00144	0.00144	CcSEcCtD
Deferiprone—Decreased appetite—Etoposide—sarcoma	0.00144	0.00144	CcSEcCtD
Deferiprone—Pancytopenia—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Deferiprone—Asthenia—Mitoxantrone—sarcoma	0.00143	0.00143	CcSEcCtD
Deferiprone—Fatigue—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Deferiprone—Jaundice—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Deferiprone—Pain—Etoposide—sarcoma	0.00142	0.00142	CcSEcCtD
Deferiprone—Neutropenia—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Deferiprone—Diarrhoea—Vincristine—sarcoma	0.0014	0.0014	CcSEcCtD
Deferiprone—Photosensitivity reaction—Doxorubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Deferiprone—Hepatobiliary disease—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Deferiprone—Weight increased—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Deferiprone—Epistaxis—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Deferiprone—Nausea—Thiotepa—sarcoma	0.00137	0.00137	CcSEcCtD
Deferiprone—Diarrhoea—Mitoxantrone—sarcoma	0.00136	0.00136	CcSEcCtD
Deferiprone—Nausea—Dactinomycin—sarcoma	0.00136	0.00136	CcSEcCtD
Deferiprone—Agranulocytosis—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Deferiprone—Pneumonia—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Deferiprone—Gastrointestinal pain—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Deferiprone—Infestation NOS—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Deferiprone—Infestation—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Deferiprone—Urticaria—Etoposide—sarcoma	0.00132	0.00132	CcSEcCtD
Deferiprone—Jaundice—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Deferiprone—Abdominal pain—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Deferiprone—Body temperature increased—Etoposide—sarcoma	0.00131	0.00131	CcSEcCtD
Deferiprone—Hepatitis—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Deferiprone—Vomiting—Vincristine—sarcoma	0.0013	0.0013	CcSEcCtD
Deferiprone—Pharyngitis—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Deferiprone—Urinary tract disorder—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Deferiprone—Rash—Vincristine—sarcoma	0.00129	0.00129	CcSEcCtD
Deferiprone—Dermatitis—Vincristine—sarcoma	0.00129	0.00129	CcSEcCtD
Deferiprone—Oedema peripheral—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Deferiprone—Connective tissue disorder—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Deferiprone—Urethral disorder—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Deferiprone—Headache—Vincristine—sarcoma	0.00128	0.00128	CcSEcCtD
Deferiprone—Hepatobiliary disease—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Deferiprone—Epistaxis—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Deferiprone—Vomiting—Mitoxantrone—sarcoma	0.00127	0.00127	CcSEcCtD
Deferiprone—Agranulocytosis—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Deferiprone—Rash—Mitoxantrone—sarcoma	0.00126	0.00126	CcSEcCtD
Deferiprone—Dermatitis—Mitoxantrone—sarcoma	0.00125	0.00125	CcSEcCtD
Deferiprone—Headache—Mitoxantrone—sarcoma	0.00125	0.00125	CcSEcCtD
Deferiprone—Eye disorder—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Deferiprone—Hypersensitivity—Etoposide—sarcoma	0.00122	0.00122	CcSEcCtD
Deferiprone—Nausea—Vincristine—sarcoma	0.00121	0.00121	CcSEcCtD
Deferiprone—Cardiac disorder—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Deferiprone—Hepatitis—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Deferiprone—Pharyngitis—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Deferiprone—Urinary tract disorder—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Deferiprone—Oedema peripheral—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Deferiprone—Asthenia—Etoposide—sarcoma	0.00119	0.00119	CcSEcCtD
Deferiprone—Connective tissue disorder—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Deferiprone—Angiopathy—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Deferiprone—Urethral disorder—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Deferiprone—Nausea—Mitoxantrone—sarcoma	0.00118	0.00118	CcSEcCtD
Deferiprone—Immune system disorder—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Deferiprone—Mediastinal disorder—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Deferiprone—Chills—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Deferiprone—Pruritus—Etoposide—sarcoma	0.00117	0.00117	CcSEcCtD
Deferiprone—Mental disorder—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Deferiprone—Malnutrition—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Deferiprone—Diarrhoea—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Deferiprone—Eye disorder—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Deferiprone—Cardiac disorder—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Deferiprone—Back pain—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Deferiprone—Angiopathy—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Deferiprone—Immune system disorder—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Deferiprone—Mediastinal disorder—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Deferiprone—Chills—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Deferiprone—Mental disorder—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Deferiprone—Vomiting—Etoposide—sarcoma	0.00105	0.00105	CcSEcCtD
Deferiprone—Malnutrition—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Deferiprone—Rash—Etoposide—sarcoma	0.00104	0.00104	CcSEcCtD
Deferiprone—Dermatitis—Etoposide—sarcoma	0.00104	0.00104	CcSEcCtD
Deferiprone—Headache—Etoposide—sarcoma	0.00104	0.00104	CcSEcCtD
Deferiprone—Back pain—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Deferiprone—Convulsion—Epirubicin—sarcoma	0.000985	0.000985	CcSEcCtD
Deferiprone—Nausea—Etoposide—sarcoma	0.000983	0.000983	CcSEcCtD
Deferiprone—Hypertension—Epirubicin—sarcoma	0.000982	0.000982	CcSEcCtD
Deferiprone—Arthralgia—Epirubicin—sarcoma	0.000968	0.000968	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000961	0.000961	CcSEcCtD
Deferiprone—Discomfort—Epirubicin—sarcoma	0.000957	0.000957	CcSEcCtD
Deferiprone—Anaphylactic shock—Epirubicin—sarcoma	0.000928	0.000928	CcSEcCtD
Deferiprone—Infection—Epirubicin—sarcoma	0.000922	0.000922	CcSEcCtD
Deferiprone—Convulsion—Doxorubicin—sarcoma	0.000912	0.000912	CcSEcCtD
Deferiprone—Nervous system disorder—Epirubicin—sarcoma	0.00091	0.00091	CcSEcCtD
Deferiprone—Hypertension—Doxorubicin—sarcoma	0.000908	0.000908	CcSEcCtD
Deferiprone—Skin disorder—Epirubicin—sarcoma	0.000901	0.000901	CcSEcCtD
Deferiprone—Hyperhidrosis—Epirubicin—sarcoma	0.000897	0.000897	CcSEcCtD
Deferiprone—Arthralgia—Doxorubicin—sarcoma	0.000896	0.000896	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00089	0.00089	CcSEcCtD
Deferiprone—Discomfort—Doxorubicin—sarcoma	0.000885	0.000885	CcSEcCtD
Deferiprone—Hypotension—Epirubicin—sarcoma	0.000867	0.000867	CcSEcCtD
Deferiprone—Anaphylactic shock—Doxorubicin—sarcoma	0.000859	0.000859	CcSEcCtD
Deferiprone—Infection—Doxorubicin—sarcoma	0.000853	0.000853	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000846	0.000846	CcSEcCtD
Deferiprone—Nervous system disorder—Doxorubicin—sarcoma	0.000842	0.000842	CcSEcCtD
Deferiprone—Skin disorder—Doxorubicin—sarcoma	0.000834	0.000834	CcSEcCtD
Deferiprone—Hyperhidrosis—Doxorubicin—sarcoma	0.00083	0.00083	CcSEcCtD
Deferiprone—Somnolence—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Deferiprone—Dyspepsia—Epirubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Deferiprone—Decreased appetite—Epirubicin—sarcoma	0.000807	0.000807	CcSEcCtD
Deferiprone—Hypotension—Doxorubicin—sarcoma	0.000802	0.000802	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000801	0.000801	CcSEcCtD
Deferiprone—Fatigue—Epirubicin—sarcoma	0.0008	0.0008	CcSEcCtD
Deferiprone—Pain—Epirubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000782	0.000782	CcSEcCtD
Deferiprone—Somnolence—Doxorubicin—sarcoma	0.000763	0.000763	CcSEcCtD
Deferiprone—Gastrointestinal pain—Epirubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Deferiprone—Dyspepsia—Doxorubicin—sarcoma	0.000756	0.000756	CcSEcCtD
Deferiprone—Decreased appetite—Doxorubicin—sarcoma	0.000746	0.000746	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000741	0.000741	CcSEcCtD
Deferiprone—Fatigue—Doxorubicin—sarcoma	0.00074	0.00074	CcSEcCtD
Deferiprone—Urticaria—Epirubicin—sarcoma	0.000737	0.000737	CcSEcCtD
Deferiprone—Pain—Doxorubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Deferiprone—Body temperature increased—Epirubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Deferiprone—Abdominal pain—Epirubicin—sarcoma	0.000734	0.000734	CcSEcCtD
Deferiprone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000702	0.000702	CcSEcCtD
Deferiprone—Hypersensitivity—Epirubicin—sarcoma	0.000684	0.000684	CcSEcCtD
Deferiprone—Urticaria—Doxorubicin—sarcoma	0.000682	0.000682	CcSEcCtD
Deferiprone—Abdominal pain—Doxorubicin—sarcoma	0.000679	0.000679	CcSEcCtD
Deferiprone—Body temperature increased—Doxorubicin—sarcoma	0.000679	0.000679	CcSEcCtD
Deferiprone—Asthenia—Epirubicin—sarcoma	0.000666	0.000666	CcSEcCtD
Deferiprone—Pruritus—Epirubicin—sarcoma	0.000657	0.000657	CcSEcCtD
Deferiprone—Diarrhoea—Epirubicin—sarcoma	0.000635	0.000635	CcSEcCtD
Deferiprone—Hypersensitivity—Doxorubicin—sarcoma	0.000633	0.000633	CcSEcCtD
Deferiprone—Asthenia—Doxorubicin—sarcoma	0.000616	0.000616	CcSEcCtD
Deferiprone—Pruritus—Doxorubicin—sarcoma	0.000608	0.000608	CcSEcCtD
Deferiprone—Vomiting—Epirubicin—sarcoma	0.00059	0.00059	CcSEcCtD
Deferiprone—Diarrhoea—Doxorubicin—sarcoma	0.000588	0.000588	CcSEcCtD
Deferiprone—Rash—Epirubicin—sarcoma	0.000585	0.000585	CcSEcCtD
Deferiprone—Dermatitis—Epirubicin—sarcoma	0.000585	0.000585	CcSEcCtD
Deferiprone—Headache—Epirubicin—sarcoma	0.000581	0.000581	CcSEcCtD
Deferiprone—Nausea—Epirubicin—sarcoma	0.000551	0.000551	CcSEcCtD
Deferiprone—Vomiting—Doxorubicin—sarcoma	0.000546	0.000546	CcSEcCtD
Deferiprone—Rash—Doxorubicin—sarcoma	0.000541	0.000541	CcSEcCtD
Deferiprone—Dermatitis—Doxorubicin—sarcoma	0.000541	0.000541	CcSEcCtD
Deferiprone—Headache—Doxorubicin—sarcoma	0.000538	0.000538	CcSEcCtD
Deferiprone—Nausea—Doxorubicin—sarcoma	0.00051	0.00051	CcSEcCtD
